Business Impact of Global Conditions, Rising Prices and Supply Chain Disruptions
First written in FY2023. 3 of 6 entries say "Worsened", first in FY2025. Latest entry: FY2026.
Immuno-Biological Laboratories moved to the "Worse" side of this theme in 2024, 1 year after the typical company in this theme (2023).
The whole theme swung hardest in 2025: 14 of 20 companies on the "Worse" side.
13 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Higher prices have continued as a result of various factors, including the weaker yen and growing instability in overseas conditions, putting upward pressure on manufacturing costs as well as selling, general and administrative expenses.」
The Company continues to recognise upward pressure on manufacturing costs and selling, general and administrative expenses from the weaker yen, instability in overseas conditions and higher prices. At the same time, it implemented cost reductions, including the consolidation of business locations and the introduction of solar power generation facilities. - FY2025WorsenedAnnual report
「As a result, cost of sales increased 11.9% year on year to ¥335.071 million.」
The impact of higher prices, the weaker yen and other factors on raw materials and expenses continued, and cost of sales increased 11.9% year on year to ¥335.071 million. - FY2024MaterialisedAnnual report
「Raw materials, expenses and other items have been significantly affected by broad-based price increases and the depreciation of the yen. As a result, cost of sales increased 11.8% year on year to ¥299.408 million.」
The impact of higher prices and the weaker yen on raw materials and expenses materialised, and cost of sales increased 11.8% year on year to ¥299.408 million. - FY2023First statedAnnual report
「Amid growing instability in global conditions and monetary tightening, raw-material and energy prices have surged and global supply-chain disruptions have caused shortages of components and semiconductors. In addition, concerns remain over an economic slowdown resulting from measures taken by countries to address high inflation, and the outlook remains uncertain.」
The Company describes external-environment risks in which surging raw-material and energy prices and supply-chain disruptions have actually affected costs and selling, general and administrative expenses.